CO-VELOCITY-GLOBAL
2.9.2020 07:04:13 CEST | Business Wire | Press release
Velocity Global , the leading provider of global expansion solutions, has selected Amsterdam, Netherlands, as the location for its European headquarters. The Denver-based company appointed Sander Poos as managing director of Europe based in Amsterdam.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200901006149/en/
As an International PEO, Velocity Global serves as an Employer of Record for supported employees in countries where clients have not set up a legal entity, enabling companies to compliantly expand internationally in a matter of weeks, and reduce their expansion costs.
“The number of clients expanding in Europe more than doubled this year compared to the same period in 2019,” said Velocity Global founder and CEO Ben Wright. “Even amidst a global pandemic, our growing clients also doubled the number of supported employees onboarded in Europe this year compared to the same period last year. Europe is critically important for both Velocity Global and our clients.”
The uptick in volume supports findings in Velocity Global’s 2020 State of Global Expansion™ report that 41 percent of tech companies in the U.S. and the UK targeted Europe as the most promising market to grow their customer base.
Amsterdam emerged as the natural choice for Velocity Global’s European headquarters as a business-friendly, culturally attractive city for international commerce. The city is geographically adjacent to key markets like Germany, France, and the United Kingdom. This year, in the final months of the Brexit transition, the European Union received approximately 80 percent of the European growth among Velocity Global clients, while the UK remains the top individual country destination.
Velocity Global established its Amsterdam presence in 2018, and now employs more than 30 team members in Europe serving in corporate and client-facing functions including client experience, employee support, operations, compliance, sales, finance, human resources, and legal.
Sander Poos leads Velocity Global’s team throughout Europe, reporting to Chief Operating Officer José Montero. He adds 25 years of experience in sales and operations in the human resources and software-as-a-service (SaaS) sectors. Poos most recently served as managing director of Benelux for Indeed.com, supporting operations in Amsterdam and Brussels as well as Dublin, Ireland. Previously he held leadership positions for companies including Xerox, Adecco, Monster.com, and Telegraaf Media Group.
“Sander brings a breadth of experience in successfully building people-focused business solutions across Europe,” said Montero. “His leadership balances revenue operations with industry-leading customer experience platforms putting people at the heart of his strategy.”
“New supported employees in Europe represent close to half of our global onboardings this year, a 40 percent increase over the first eight months of 2019,” said Poos. “I am excited to lead European growth for Velocity Global and our clients.”
The company's European team supports 19 languages from Europe, the Middle East, Africa, and Asia, contributing to the 36 languages supported worldwide by Velocity Global. Velocity Global has 250 employees located in 14 countries serving thousands of supported employees for clients in over 100 countries.
ABOUT VELOCITY GLOBAL
Velocity Global is the leading provider of global employment solutions that has reinvented the way companies expand overseas. With unrivaled expertise in over 185 countries, Velocity Global delivers end-to-end services and best-in-class support to help companies confidently navigate the entire lifecycle of international business. To ensure a compliant, efficient, and flexible international expansion, Velocity Global provides a comprehensive suite of global services that includes International PEO, Entity Setup and Support, Global Talent Acquisition, Immigration, and Consulting.
ABOUT SANDER POOS
Sander leads Velocity Global’s European team, responsible for the company’s business activities in the region, including all operations functions, customer experience, service delivery, and partner network alignment. He is a Dutch native based at the company’s European regional headquarters in Amsterdam.
Sander applies 25 years of experience in sales and operations in the human resources and software-as-a-service (SaaS) sectors. He most recently served as managing director of Benelux for Indeed.com, supporting operations in Amsterdam and Brussels as well as Dublin, Ireland. Previously, Sander held leadership positions for companies including Xerox, Adecco, Monster.com, and Telegraaf Media Group.
He received dual university degrees in Labor Market Politics and Personnel Policy, and Catholic Teaching from HAS Den Bosch University Holland, and an MBA from the Imperial College Business School in London. In his free time, he enjoys spending time with his family and playing tennis, and serves on the Board of the Dutch Tennis Association.
See biographies for Velocity Global leaders here .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200901006149/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 09:31:00 CEST | Press release
Peyman Kargar appointed Director and Chief Executive Officer of TVS Motor Company, effective January 27, 2027 K. N. Radhakrishnan to continue as Director and Chief Executive Officer until then and subsequently will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027 Appointment supports TVS Motor Company's next phase of growth and innovation TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 21:27:00 CEST | Press release
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom